NCT02229357View on ClinicalTrials.gov

Evaluation of Priming Effects by PLAI Vaccine on the Subsequent Response to Inactivated H5N1 Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Avian Influenza
Interventions
BIOLOGICAL

OrniFlu® inactivated vaccine

All subjects will receive a single dose of an H5 inactivated influenza vaccine after blood collection for immunology assays

Trial Locations (1)

10400

Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok

All Listed Sponsors
collaborator

The Government Pharmaceutical Organization

OTHER_GOV

collaborator

World Health Organization

OTHER

lead

Mahidol University

OTHER

NCT02229357 - Evaluation of Priming Effects by PLAI Vaccine on the Subsequent Response to Inactivated H5N1 Vaccine | Biotech Hunter | Biotech Hunter